Spine biologic procedure found safe and effective in 3-year study

Biologics

Three-year data for the Discseel spine procedure found it was effective and could replace most spine surgeries, Discseel Technologies said Dec. 4. 

Four things to know:

1. The study, published in Pain Physician Journal, studied Discseel for treating chronic low back pain and sciatica, according to a news release. 

2. The study of 725 individuals showed statistically significant improvement in all measured outcomes at 1-, 2- and 3-years after undergoing the procedure. 

3. Patients enrolled in the study were eligible if they failed "a combination of at least four prior treatments including surgical fusion, laminectomy, discectomy, stem cell injection, and other invasive treatments," Kevin Pauza, MD, the study's lead investigator said in the release.

4. Discseel is an outpatient spine procedure that uses a Fibrin biologic drug to seal disc damage and stimulate growth. 

Copyright © 2024 Becker's Healthcare. All Rights Reserved. Privacy Policy. Cookie Policy. Linking and Reprinting Policy.

 

Articles We Think You'll Like

 

Featured Webinars

Featured Whitepapers